Reducing Delay in Vaccination of Children: Logistic Barriers

Communicable Disease Clinical Trial

— REDIVAC-LB  

Official title:

The REDIVAC Study-Reducing Delay in Vaccination of Children Study

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03516682
• Other study ID #: 1R01HD079457
• Status: Completed
• Phase: N/A
• Start date: June 1, 2018
• Est. completion date: March 31, 2019

Study information

• Verified date: August 2018
• Source: Kaiser Permanente
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This study will assess the impact of automated reminders for the 6 month and 12 month vaccine visits to increase vaccination in parents experiencing logistic barriers to vaccination.

Description:

Parents of children less than 11 months of age will be identified as delayed or missing vaccinations due to logistic barriers in the Kaiser Permanente Colorado population. Parents identified will be randomized to the intervention arm or the usual care arm. Those in the intervention arm will receive automated reminders for the 6 month and 12 month vaccine visits. Reminders will include scheduling information as well as access to a website with vaccine and scheduling information. They will also have an opportunity to provide preferences in how they receive the automated reminders (text, phone or email). There will be 2 reminders before the 6 and 12 month visits and 2 after the 6 and 12 month visits. Parents will be excluded from receiving reminders if they have received vaccines within the time frame when they are eligible to receive another vaccine or have a well child visit scheduled.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 250
• Est. completion date: March 31, 2019
• Est. primary completion date: March 31, 2019
• Accepts healthy volunteers: No
• Gender: All
• Age group: 1 Month to 11 Months

Eligibility

Inclusion Criteria:

• Parents of children less than 11 months of age

• Currently enrolled at Kaiser Permanente Colorado at the time of identification

• The child is missing recommended vaccinations

Exclusion Criteria:

• Non-english speaking

• diagnosis code indicating parent vaccine refusal

Related Conditions & MeSH terms

• Communicable Disease
• Communicable Diseases
• Infection

Intervention

Behavioral:
• Reminders
Automated reminders for the 6 month and 12 month vaccine visits for parents experiencing logistic barriers to vaccination.

Locations

Country	Name	City	State
United States	Kaiser Permanente Colorado Institute for Health Research	Denver	Colorado

Sponsors (2)

Lead Sponsor	Collaborator
Kaiser Permanente	University of Colorado, Denver

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Vaccines received (Electronic Health Record)	Vaccination records from the participants electronic health record will be used to measure vaccines received. Vaccines received is a dichotomous variable indicating if any vaccines were received while enrolled in the study	up to a year of follow up
Secondary	Vaccine dose (Electronic Health Record)	Vaccination records from the participants electronic health record will be used to measure vaccine dose. Vaccine dose is a measure of the vaccine doses that the child could have received while enrolled in the study, the number of vaccine doses received	up to a year of follow up